The first half of the year is almost in the bag, and while the major market indexes continue their overall trend higher, the IPO market has been 2019’s biggest unsung winner. While strong economic data and a broader market rally are cited as the IPO market’s biggest drivers, much of the bullish sentiment can be […]
Read MoreOne of the year’s biggest merger announcements sent shockwaves through the U.S. pharmaceutical sector on Tuesday when Humira drugmaker AbbVie Inc. (ABBV) struck a deal to acquire Botox producer Allergan Plc. (AGN). Investors reacted strongly to the news, making ABBV and AGN the market’s single biggest loser and winner, respectively. After the deal closes, AbbVie […]
Read MoreIf you’ve followed my highlights in this space, you’ve seen me write on a number of occasions about how my value-focused investing approach tends to make me think in defensive terms under current market conditions. As the major indices are driving to new all-time highs, a lot of growth-oriented folks think that sounds pretty silly; […]
Read More